Does TACROLIMUS\TACROLIMUS ANHYDROUS Cause Thrombotic microangiopathy? 137 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 137 reports of Thrombotic microangiopathy have been filed in association with TACROLIMUS\TACROLIMUS ANHYDROUS. This represents 2.0% of all adverse event reports for TACROLIMUS\TACROLIMUS ANHYDROUS.
137
Reports of Thrombotic microangiopathy with TACROLIMUS\TACROLIMUS ANHYDROUS
2.0%
of all TACROLIMUS\TACROLIMUS ANHYDROUS reports
30
Deaths
61
Hospitalizations
How Dangerous Is Thrombotic microangiopathy From TACROLIMUS\TACROLIMUS ANHYDROUS?
Of the 137 reports, 30 (21.9%) resulted in death, 61 (44.5%) required hospitalization, and 24 (17.5%) were considered life-threatening.
Is Thrombotic microangiopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TACROLIMUS\TACROLIMUS ANHYDROUS. However, 137 reports have been filed with the FAERS database.
What Other Side Effects Does TACROLIMUS\TACROLIMUS ANHYDROUS Cause?
Off label use (708)
Death (321)
Transplant rejection (278)
Diarrhoea (257)
Pyrexia (243)
Alopecia (232)
Drug ineffective (198)
Transplant dysfunction (198)
Hospitalisation (194)
Pneumonia (193)
What Other Drugs Cause Thrombotic microangiopathy?
TACROLIMUS (1,982)
MYCOPHENOLATE MOFETIL (820)
CYCLOSPORINE (724)
GEMCITABINE (648)
ECULIZUMAB (636)
CYCLOPHOSPHAMIDE (602)
FLUDARABINE (480)
METHOTREXATE (447)
CARFILZOMIB (350)
METHYLPREDNISOLONE (345)
Which TACROLIMUS\TACROLIMUS ANHYDROUS Alternatives Have Lower Thrombotic microangiopathy Risk?
TACROLIMUS\TACROLIMUS ANHYDROUS vs TADALAFIL
TACROLIMUS\TACROLIMUS ANHYDROUS vs TAFAMIDIS
TACROLIMUS\TACROLIMUS ANHYDROUS vs TAFAMIDIS MEGLUMINE
TACROLIMUS\TACROLIMUS ANHYDROUS vs TAFASITAMAB
TACROLIMUS\TACROLIMUS ANHYDROUS vs TAFASITAMAB-CXIX